{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:41:58Z","timestamp":1792129318604,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Macrolides, including azithromycin, are increasingly used in preterm-born infants to treat<jats:italic>Ureaplasma<\/jats:italic>infections. The baseline carriage of macrolide resistance genes in the preterm stool microbiota is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Identify carriage of azithromycin resistant bacteria and the incidence of macrolide resistant genes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Azithromycin resistant bacteria were isolated from serial stool samples obtained from preterm infants (\u226432 weeks\u2019 gestation) by culturing aerobically\/anaerobically, in the presence\/absence of azithromycin. Using quantitative PCR, we targeted 6 common macrolide resistance genes (<jats:italic>erm(A)<\/jats:italic>,<jats:italic>erm(B)<\/jats:italic>,<jats:italic>erm(C)<\/jats:italic>,<jats:italic>erm(F)<\/jats:italic>,<jats:italic>mef(A\/E), msr(A)<\/jats:italic>) in DNA extracted from selected bacteria resistant to azithromycin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>From 89 stool samples from 37 preterm-born infants, 93.3% showed bacterial growth in aerobic or anaerobic conditions. From the 280 azithromycin resistant isolates that were identified,<jats:italic>Staphylococcus<\/jats:italic>(75%) and<jats:italic>Enterococcus<\/jats:italic>(15%) species dominated. Macrolide resistance genes were identified in 91% of resistant isolates: commonest were<jats:italic>erm(C)<\/jats:italic>(46% of isolates) and<jats:italic>msr(A)<\/jats:italic>(40%). Multiple macrolide resistance genes were identified in 18% of isolates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Macrolide resistance is common in the gut microbiota of preterm-born infants early in life, most likely acquired from exposure to the maternal microbiota. It will be important to assess modulation of macrolide resistance, if macrolide treatment becomes routine in the management of preterm infants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Impact Statement<\/jats:title><jats:p><jats:list list-type=\"bullet\"><jats:list-item><jats:p>Azithromycin resistance is present in the stool microbiota in the first month of life in preterm infants<\/jats:p><\/jats:list-item><jats:list-item><jats:p>91% of azithromycin resistant bacteria carried at least one of 6 common macrolide resistant genes<\/jats:p><\/jats:list-item><jats:list-item><jats:p>Increasing use of macrolides in the preterm population makes this an important area of study<\/jats:p><\/jats:list-item><\/jats:list><\/jats:p><\/jats:sec>","DOI":"10.1038\/s41390-023-02743-7","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T13:03:07Z","timestamp":1691413387000},"page":"205-212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Baseline azithromycin resistance in the gut microbiota of preterm born infants"],"prefix":"10.1038","volume":"95","author":[{"given":"David J.","family":"Gallacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali F.","family":"Aboklaish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Wach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian R.","family":"Marchesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sailesh","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"key":"2743_CR1","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1136\/archdischild-2019-318122","volume":"105","author":"RM Viscardi","year":"2020","unstructured":"Viscardi, R. M. et al. Randomised trial of azithromycin to eradicate Ureaplasma in preterm infants. Arch. Dis. Child. Fetal Neonatal Ed. 105, 615\u2013622 (2020).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"2743_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1159\/000363493","volume":"106","author":"V Nair","year":"2014","unstructured":"Nair, V., Loganathan, P. & Soraisham, A. S. Azithromycin and other macrolides for prevention of bronchopulmonary dysplasia: A systematic review and meta-analysis. Neonatology 106, 337\u2013347 (2014).","journal-title":"Neonatology"},{"key":"2743_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/INF.0000000000000239","volume":"33","author":"J Lowe","year":"2014","unstructured":"Lowe, J. et al. Association between pulmonary ureaplasma colonization and bronchopulmonary dysplasia in preterm infants: updated systematic review and meta-analysis. Pediatr. Infect. Dis. J. 33, 697\u2013702 (2014).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2743_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/0-387-33026-7_9","volume":"582","author":"PL Davies","year":"2006","unstructured":"Davies, P. L., Maxwell, N. C. & Kotecha, S. The role of inflammation and infection in the development of chronic lung disease of prematurity. Adv. Exp. Med. Biol. 582, 101\u2013110 (2006).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2743_CR5","doi-asserted-by":"publisher","first-page":"e041528","DOI":"10.1136\/bmjopen-2020-041528","volume":"10","author":"J Lowe","year":"2020","unstructured":"Lowe, J. et al. Study protocol: Azithromycin therapy for chronic lung disease of prematurity (AZTEC) - A randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants. BMJ Open 10, e041528 (2020).","journal-title":"BMJ Open"},{"key":"2743_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06730-x","volume":"23","author":"SJ Kotecha","year":"2022","unstructured":"Kotecha, S. J. et al. Follow-up study of infants recruited to the randomised, placebo-controlled trial of azithromycin for the prevention of chronic lung disease of prematurity in preterm infants-study protocol for the AZTEC-FU study. Trials 23, 796 (2022).","journal-title":"Trials"},{"key":"2743_CR7","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJMoa2002606","volume":"383","author":"T Doan","year":"2020","unstructured":"Doan, T. et al. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution. N. Engl. J. Med. 383, 1941\u20131950 (2020).","journal-title":"N. Engl. J. Med."},{"key":"2743_CR8","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13756-020-00783-w","volume":"9","author":"RS Djamin","year":"2020","unstructured":"Djamin, R. S. et al. Prevalence and abundance of selected genes conferring macrolide resistance genes in COPD patients during maintenance treatment with azithromycin. Antimicrob. Resist. Infect. Control 9, 116 (2020).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"2743_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/jac\/dkl014","volume":"57","author":"SJ Phaff","year":"2006","unstructured":"Phaff, S. J., Tiddens, H. A. W. M., Verbrugh, H. A. & Ott, A. Macrolide resistance of Staphylococcus aureus and Haemophilus species associated with long-term azithromycin use in cystic fibrosis. J. Antimicrob. Chemother. 57, 741\u2013746 (2006).","journal-title":"J. Antimicrob. Chemother."},{"key":"2743_CR10","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1542\/neo.20-3-e135","volume":"20","author":"CB Ramirez","year":"2019","unstructured":"Ramirez, C. B. & Cantey, J. B. Antibiotic Resistance in the Neonatal Intensive Care Unit. Neoreviews 20, e135\u2013e144 (2019).","journal-title":"Neoreviews"},{"key":"2743_CR11","doi-asserted-by":"publisher","first-page":"11971","DOI":"10.1073\/pnas.1002601107","volume":"107","author":"MG Dominguez-Bello","year":"2010","unstructured":"Dominguez-Bello, M. G. et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc. Natl Acad. Sci. USA 107, 11971\u201311975 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2743_CR12","doi-asserted-by":"publisher","first-page":"1901909","DOI":"10.1183\/13993003.01909-2019","volume":"55","author":"D Gallacher","year":"2020","unstructured":"Gallacher, D. et al. Dissimilarity of the gut-lung axis and dysbiosis of the lower airways in ventilated preterm infants. Eur. Respir. J. 55, 1901909 (2020).","journal-title":"Eur. Respir. J."},{"key":"2743_CR13","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/nu10030274","volume":"10","author":"CYL Chong","year":"2018","unstructured":"Chong, C. Y. L., Bloomfield, F. H. & O\u2019Sullivan, J. M. Factors Affecting Gastrointestinal Microbiome Development in Neonates. Nutrients 10, 274 (2018).","journal-title":"Nutrients"},{"key":"2743_CR14","doi-asserted-by":"publisher","first-page":"S209","DOI":"10.1093\/infdis\/jiaa497","volume":"223","author":"WE Anthony","year":"2021","unstructured":"Anthony, W. E., Burnham, C. A. D., Dantas, G. & Kwon, J. H. The Gut Microbiome as a Reservoir for Antimicrobial Resistance. J. Infect. Dis. 223, S209\u2013S213 (2021).","journal-title":"J. Infect. Dis."},{"key":"2743_CR15","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.cmi.2020.03.021","volume":"26","author":"LE Papanicolas","year":"2020","unstructured":"Papanicolas, L. E., Warner, M., Wesselingh, S. L. & Rogers, G. B. Protect commensal gut bacteria to improve antimicrobial stewardship. Clin. Microbiol. Infect. 26, 814\u2013815 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"2743_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1017\/S2040174415001506","volume":"7","author":"MJ Gosalbes","year":"2016","unstructured":"Gosalbes, M. J. et al. High frequencies of antibiotic resistance genes in infants\u2019 meconium and early fecal samples. J. Dev. Orig. Health Dis. 7, 35\u201344 (2016).","journal-title":"J. Dev. Orig. Health Dis."},{"key":"2743_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fcimb.2020.00332","volume":"10","author":"TE Klassert","year":"2020","unstructured":"Klassert, T. E. et al. Early Bacterial Colonization and Antibiotic Resistance Gene Acquisition in Newborns. Front. Cell. Infect. Microbiol. 10, 332 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2743_CR18","doi-asserted-by":"publisher","first-page":"e21644","DOI":"10.1371\/journal.pone.0021644","volume":"6","author":"LE de Vries","year":"2011","unstructured":"de Vries, L. E. et al. The gut as reservoir of antibiotic resistance: microbial diversity of tetracycline resistance in mother and infant. PLoS One 6, e21644 (2011).","journal-title":"PLoS One"},{"key":"2743_CR19","doi-asserted-by":"publisher","first-page":"7134","DOI":"10.1128\/AEM.05087-11","volume":"77","author":"L Zhang","year":"2011","unstructured":"Zhang, L. et al. Acquired antibiotic resistance: are we born with it? Appl. Environ. Microbiol. 77, 7134\u20137141 (2011).","journal-title":"Appl. Environ. Microbiol."},{"key":"2743_CR20","doi-asserted-by":"publisher","first-page":"e2928","DOI":"10.7717\/peerj.2928","volume":"5","author":"G Rose","year":"2017","unstructured":"Rose, G. et al. Antibiotic resistance potential of the healthy preterm infant gut microbiome. PeerJ 5, e2928 (2017).","journal-title":"PeerJ"},{"key":"2743_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/19490976.2016.1218584","volume":"7","author":"AJ Gasparrini","year":"2016","unstructured":"Gasparrini, A. J. et al. Antibiotic perturbation of the preterm infant gut microbiome and resistome. Gut Microbes 7, 443\u2013449 (2016).","journal-title":"Gut Microbes"},{"key":"2743_CR22","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1099\/00207713-52-6-2141","volume":"52","author":"SH Duncan","year":"2002","unstructured":"Duncan, S. H., Hold, G. L., Harmsen, H. J. M., Stewart, C. S. & Flint, H. J. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int. J. Syst. Evol. Microbiol 52, 2141\u20132146 (2002).","journal-title":"Int. J. Syst. Evol. Microbiol"},{"key":"2743_CR23","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature17645","volume":"533","author":"HP Browne","year":"2016","unstructured":"Browne, H. P. et al. Culturing of \u2018unculturable\u2019 human microbiota reveals novel taxa and extensive sporulation. Nature 533, 543\u2013546 (2016).","journal-title":"Nature"},{"key":"2743_CR24","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1128\/AAC.42.2.414","volume":"42","author":"F Fuentes","year":"1998","unstructured":"Fuentes, F., Izquierdo, J., Mart\u00edn, M. M., Gomez-Lus, M. L. & Prieto, J. Postantibiotic and Sub-MIC Effects of Azithromycin and Isepamicin against Staphylococcus aureus and Escherichia coli. Antimicrob. Agents Chemother. 42, 414 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"2743_CR25","doi-asserted-by":"crossref","first-page":"D517","DOI":"10.1093\/nar\/gkz1136","volume":"48","author":"BP Alcock","year":"2020","unstructured":"Alcock, B. P. et al. CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res. 48, D517\u2013D525 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2743_CR26","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser, A. et al. Primer3\u2014new capabilities and interfaces. Nucleic Acids Res. 40, e115 (2012).","journal-title":"Nucleic Acids Res."},{"key":"2743_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.diagmicrobio.2011.08.017","volume":"71","author":"V Srinivasan","year":"2011","unstructured":"Srinivasan, V., du Plessis, M., Beall, B. W. & McGee, L. Quadriplex real-time polymerase chain reaction (lytA, mef, erm, pbp2bwt) for pneumococcal detection and assessment of antibiotic susceptibility. Diagn. Microbiol. Infect. Dis. 71, 453\u2013456 (2011).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"2743_CR28","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596 (2013).","journal-title":"Nucleic Acids Res."},{"key":"2743_CR29","doi-asserted-by":"publisher","first-page":"D633","DOI":"10.1093\/nar\/gkt1244","volume":"42","author":"JR Cole","year":"2014","unstructured":"Cole, J. R. et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 42, D633\u2013D642 (2014).","journal-title":"Nucleic Acids Res."},{"key":"2743_CR30","doi-asserted-by":"publisher","first-page":"7537","DOI":"10.1128\/AEM.01541-09","volume":"75","author":"PD Schloss","year":"2009","unstructured":"Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 75, 7537\u20137541 (2009).","journal-title":"Appl. Environ. Microbiol."},{"key":"2743_CR31","unstructured":"R Core Team. R: Language and Environment for Statistical Computing. (2017)."},{"key":"2743_CR32","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.chom.2015.04.004","volume":"17","author":"F B\u00e4ckhed","year":"2015","unstructured":"B\u00e4ckhed, F. et al. Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell Host Microbe 17, 690\u2013703 (2015).","journal-title":"Cell Host Microbe"},{"key":"2743_CR33","doi-asserted-by":"publisher","DOI":"10.1086\/324626","author":"R Leclercq","year":"2002","unstructured":"Leclercq, R. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin. Infect. Dis. https:\/\/doi.org\/10.1086\/324626 (2002).","journal-title":"Clin. Infect. Dis."},{"key":"2743_CR34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.plasmid.2018.05.001","volume":"99","author":"AT Fe\u00dfler","year":"2018","unstructured":"Fe\u00dfler, A. T., Wang, Y., Wu, C. & Schwarz, S. Mobile macrolide resistance genes in staphylococci. Plasmid 99, 2\u201310 (2018).","journal-title":"Plasmid"},{"key":"2743_CR35","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1128\/AEM.67.2.561-568.2001","volume":"67","author":"NB Shoemaker","year":"2001","unstructured":"Shoemaker, N. B., Vlamakis, H., Hayes, K. & Salyers, A. A. Evidence for Extensive Resistance Gene Transfer among Bacteroides spp. and among Bacteroides and Other Genera in the Human Colon. Appl. Environ. Microbiol. 67, 561 (2001).","journal-title":"Appl. Environ. Microbiol."},{"key":"2743_CR36","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1093\/jac\/dkm327","volume":"60","author":"N Karami","year":"2007","unstructured":"Karami, N. et al. Transfer of an ampicillin resistance gene between two Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics. J. Antimicrob. Chemother. 60, 1142\u20131145 (2007).","journal-title":"J. Antimicrob. Chemother."},{"key":"2743_CR37","first-page":"1","volume":"1","author":"MK Gibson","year":"2016","unstructured":"Gibson, M. K. et al. Developmental dynamics of the preterm infant gut microbiota and antibiotic resistome. Nat. Microbiol. 2016 14 1, 1\u201310 (2016).","journal-title":"Nat. Microbiol. 2016 14"},{"key":"2743_CR38","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13756-019-0583-6","volume":"8","author":"G Casaburi","year":"2019","unstructured":"Casaburi, G. et al. Early-life gut microbiome modulation reduces the abundance of antibiotic-resistant bacteria. Antimicrob. Resist. Infect. Control 8, 131 (2019).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"2743_CR39","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41564-019-0550-2","volume":"4","author":"AJ Gasparrini","year":"2019","unstructured":"Gasparrini, A. J. et al. Metagenomic signatures of early life hospitalization and antibiotic treatment in the infant gut microbiota and resistome persist long after discharge. Nat. Microbiol. 4, 2285 (2019).","journal-title":"Nat. Microbiol."},{"key":"2743_CR40","first-page":"1","volume":"34","author":"MT Alou","year":"2020","unstructured":"Alou, M. T. et al. State of the Art in the Culture of the Human Microbiota: New Interests and Strategies. Clin. Microbiol. Rev. 34, 1\u201321 (2020).","journal-title":"Clin. Microbiol. Rev."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02743-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02743-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02743-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T20:39:26Z","timestamp":1729888766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02743-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["2743"],"URL":"https:\/\/doi.org\/10.1038\/s41390-023-02743-7","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"assertion":[{"value":"10 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was provided for sample collection, storage and analysis by the parents of each recruited participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}